Nova Ltd. Profile Avatar - Palmy Investing

Nova Ltd.

Nova Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel, Taiwan, the United States, China, Korea, and internationally. Its product portfolio includes a set of metrology platforms for di…
Semiconductors
IL, Rehovot [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 0% Bad
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 100% Best
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 12.60 127.31 113.06
Graham Fair Price 0.86 27.91 27.68
PEG 425.64 -11.48 2.18
Price/Book 23.15 6.53 5.30
Price/Cash Flow -44.91 91.23 165.60
Prices/Earnings 34.13 35.07 26.14
Price/Sales 22.94 36.46 29.66
Price/FCF -44.91 91.23 165.60
Naive Interpretation member
01 - Valuation · Bad
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 6.48 0.59 0.55
Operating Margin 4.66 0.26 0.25
ROA -7.71 0.03 0.03
ROE 0.05 0.05 -8.19
ROIC 0.03 0.03 -2.47
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ < 0.005 0.01 -48.97
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -0.01 0.11 642.67
EPS QOQ 0.12 -0.03 -74.48
FCF QOQ -0.44 1.36 206.65
Revenue QOQ 0.04 0.06 34.42
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 206.58 228.20 10.46
Days Sales Outstanding (DSO) 74.60 63.09 -15.44
Inventory Turnover 0.44 0.39 -9.47
Debt/Capitalization 0.25 0.23 -4.34
Quick Ratio 1.72 1.76 2.28
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 25.91 27.27 5.27
Cash 15.31 17.07 11.48
Capex -0.25 -0.10 62.15
Free Cash Flow 0.83 1.95 135.29
Revenue 4.63 4.88 5.45
Naive Interpretation member
05 - Per Share Metrics · Best
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 2.20 2.26 2.56
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 3.75 3.00 -20.00
Naive Interpretation Member
06 - Financial Health · Bad
End of NVMI's Analysis
CIK: 1109345 CUSIP: M7516K103 ISIN: IL0010845571 LEI: - UEI: -
Secondary Listings
NVMI has no secondary listings inside our databases.